Psilocybin or Ketamine for Alcohol Use Disorder: An Active Comparator Trial

Abroad (travel likely)RecruitingPHASE2

Conditions

Alcohol Use Disorder · Alcohol Dependence · Alcohol Abuse

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

University of Iowa Health Care, Iowa City, Iowa, United States
Contact: Study coordinator (Lindsay E Golden) · lindsay-golden@uiowa.edu

Study leads

Peggy C Nopoulos, MD
Principal Investigator
University of Iowa

View source on ClinicalTrials.gov

Similar trials

Other trials that are currently recruiting and may be relevant based on condition, treatment, phase, or location

Reducing Hazardous Alcohol Use and Optimizing Treatment as Prevention Among Men Living With HIV in Risk Environments

HIV Antiretroviral Therapy (ART) Adherence · Alcohol Abuse · HIV Infection

Abroad (travel likely)Recruiting

Kampala, Uganda

Validation of the French Version of the Prediction of the Alcohol Withdrawal Severity Scale (PAWSS)

Addiction, Substance · Alcohol Use Disorder · Alcohol Dependence

Abroad (travel likely)Recruiting

Étampes, France

Intestinal Microbiota Transplant in Alcohol-Associated Liver Disease

Liver Disease; Alcohol-Related · Cirrhosis · Alcohol Use Disorder

Abroad (travel likely)RecruitingPHASE1, PHASE2

Richmond, United States · Richmond, United States

Guanfacine for Alcohol Use Disorder (AUD)

Alcohol Use Disorder

Abroad (travel likely)RecruitingPHASE2

Indianapolis, United States · Newark, United States